National Neurological Diseases Surveillance System Act of 2010

Stem Cell Research Improvement Act of 2009 allows for federal funding of embryonic stem cell research provided that certain ethical requirements are met (HR 873 and S 487). Supported the Cord Blood Education and Awareness Acts (H.R. 2107) inclusion in legislation being drafted to reauthorize the C.W. Young Cell Transplantation Program. H.R. 2107 would require uniform and medically accurate information to be developed by the Department of Health and Human Services and disseminated by maternal healthcare providers. Supported HR 1362 for MS and Parkinsons research.

Client expense: $80,000 · Firm income: Not reported

Government targets: AMTRAK - Natl Railroad Passenger Corporation, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

HR 1362: NATIONAL NEUROLOGICAL DISEASES SURVEILLANCE SYSTEM ACT OF 2010; ALL PROVISIONS OF THE BILL HR 3082: CONTINUING APPROPRIATIONS AND SURFACE TRANSPORTATION EXTENSIONS ACT, 2011; ALL PROVISIONS OF THE BILL S 1273: NATIONAL MS AND PARKINSON'S DISEASE REGISTRIES ACT; ALL PROVISIONS OF THE BILL

Client expense: $670,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4678 Foreign Manufacturers Legal Accountability Act H.R. 1362 National Neurological Diseases Surveillance System Act of 2010 S. 1273 National MS and Parkinson's Disease Registries Act

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: Not reported · Firm income: Not reported

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: Not reported · Firm income: Not reported

-S. 1273, National MS and Parkinson's Disease Registries Act, support all provisions. -H.R. 1362, National Neurological Diseases Surveillance System Act, support all provisions. -H.R. 5732, Part D Off-label Prescription Parity Act, support all provisions. -H.R. 6208, Adult Day Achievement Center Enhancement Act, support all provisions. -S. 1630/H.R. 3799, Affordable Access to Prescription Medications Act, support all provisions.

Client expense: $94,501 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Stem Cell Research Improvement Act of 2009 allows for federal funding of embryonic stem cell research provided that certain ethical requirements are met (HR 873 and S 487). Supported the Cord Blood Education and Awareness Acts (H.R. 2107) inclusion in legislation being drafted to reauthorize the C.W. Young Cell Transplantation Program. H.R. 2107 would require uniform and medically accurate information to be developed by the Department of Health and Human Services and disseminated by maternal healthcare providers. Supported HR 1362 for MS and Parkinsons research.

Client expense: $80,000 · Firm income: Not reported

Government targets: AMTRAK - Natl Railroad Passenger Corporation, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

H.R. 1362, "The National Neurological Diseases Surveillance System Act," all sections; S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; H.R.5732, "Part D Off-Label Prescription Parity Act," all sections; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the National Institutes of Health (NIH), Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and regulatory science; H.R 4808, "Stem Cell Research Advancement Act of 2009," all sections; S. 3766, "The Stem Cell Research Advancement Act of 2010," all sections; legislation and regulation relating to the extension of the Medicare Part B therapy cap exceptions process and Multiple Procedure Payment Reduction Policy for rehabilitation services; HR 1347, "The Concussion Treatment and Care Tools Act of 2009," all sections; and Fiscal Year 2012 funding for the NIH Institute on Aging.

Client expense: $10,000 · Firm income: Not reported

H.R. 4678 Foreign Manufacturers Legal Accountability Act H.R. 1362 National Neurological Diseases Surveillance System Act of 2010 Multiple Sclerosis outreach

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 4678/S 1606: FOREIGN MANUFACTURERS LEGAL ACCOUNTABILITY ACT OF 2010; ALL PROVISIONS OF THE BILL HR 1362: NATIONAL NEUROLOGICAL DISEASES SURVEILLANCE SYSTEM ACT OF 2010; ALL PROVISIONS OF THE BILL MULTIPLE SCLEROSIS OUTREACH

Client expense: $610,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for funding for the National Istitutes of Health. Support for HR 1362 to create a neurodisease surveillance program

Client expense: $92,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-S. 1273, National MS and Parkinson's Disease Registries Act, support all provisions. -H.R. 1362, National Neurological Diseases Surveillance System Act, support all provisions. -H.R. 5732, Part D Off-label Prescription Parity Act, support all provisions. -HR 1586, Education Jobs and Medicaid Assistance Act, support extension of federal Medicaid assistance to states. -H.R. 6208, Adult Day Achievement Center Enhancement Act, support all provisions. -S. 1630/H.R. 3799, Affordable Access to Prescription Medications Act, support all provisions.

Client expense: $94,501 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Stem Cell Research Improvement Act of 2009 allows for federal funding of embryonic stem cell research provided that certain ethical requirements are met (HR 873 and S 487). Supported the Cord Blood Education and Awareness Acts (H.R. 2107) inclusion in legislation being drafted to reauthorize the C.W. Young Cell Transplantation Program. H.R. 2107 would require uniform and medically accurate information to be developed by the Department of Health and Human Services and disseminated by maternal healthcare providers. Supported HR 1362 for MS and Parkinsons research.

Client expense: $80,000 · Firm income: Not reported

Government targets: AMTRAK - Natl Railroad Passenger Corporation, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Social Security Administration (SSA), Veterans Affairs, Dept of (VA)

HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; ALL PROVISIONS OF THE BILL TRI CAUCUS HEALTHCARE REFORM BILL; BILL NOT YET INTRODUCED; ALL PROVISIONS OF THE BILL S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009; ALL PROVISIONS OF THE BILL S.301: PHYSICIAN PAYMENTS SUNSHINE ACT OF 2009; ALL PROVISIONS OF THE BILL S 1110: MEDICARE PAYMENT ADVISORY COMMISSION (MEDPAC) REFORM ACT OF 2009; ALL PROVISIONS OF THE BILL HR 2502: COMPARATIVE EFFECTIVENESS RESEARCH ACT OF 2009; ALL PROVISIONS OF THE BILL S 1213: PATIENT CENTERED OUTCOMES RESEARCH ACT OF 2009; ALL PROVISIONS OF THE BILL HR 3962: AFFORDABLE HEALTH CARE FOR AMERICA ACT OF 2009; ALL PROVISIONS OF THE BILL HR 3590: PATIENT PROTECTION & AFFORDABLE CARE ACT OF 2009; ALL PROVISIONS OF THE BILL S 1679: AFFORDABLE HEALTH CHOICES ACT OF 2009; ALL PROVISIONS OF THE BILL HR 1362/S 1273: NATIONAL MS AND PARKINSON'S DISEASE REGISTRIES ACT; ALL PROVISIONS OF THE BILL DEPARTMENT OF DEFENSE APPROPRIATIONS: BILL NOT YET INTRODUCED; MS RESEARCH FUNDING NATIONAL ACTION PLAN FOR INFERTILITY

Client expense: $780,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; "Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2011," all sections relating to the NIH, Cures Acceleration Network at NIH, and National Institute of Environmental Health Sciences; "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2011," all sections regarding the FDA and a new review divison for Biochemical and Genetic Diseases within the Center for Drug Evaluation Research, Office of New Drugs at FDA; "Supplemental Appropriations Act, 2010," section relating to the limitation on use of funds available to the Department of Veterans Affairs; "Energy and Water Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; "Interior, Environment, and Related Agencies Appropriations Act, 2011," sections relating to the National Institute of Environmental Health Sciences; H.R 4808, "Stem Cell Research Enhancement Act of 2009," all sections; and legislation relating to the extension of the Medicare Part B therapy cap exceptions process.

Client expense: Not reported · Firm income: Not reported

-S. 1273/H.R. 1362, National MS and Parkinson's Disease Registries Act, support all provisions. -S. 1630/H.R. 3799, Affordable Access to Prescription Medications Act, support all provisions. -H.R. 4213, American Jobs and Closing Tax Loopholes Act, support inclusion of COBRA premium assistance extension and of federal Medicaid assistance extension in the form of a temporarily enhanced Federal Medical Assistance Percentage (FMAP). -S. 3548, Extend COBRA Premium Assistance Program Act, support all provisions. -H.R. 3421, Medical Debt Relief Act, support all provisions. -H.R. 3043, Medicare Adult Day Care Services Act, support all provisions.

Client expense: $94,501 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA)

H.R. 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2011," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," section 10409 relating to Cures Acceleration Network, sections relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, section relating to Medicare Part B therapy cap exceptions process, sections relating to Medicaid eligibility levels; H.R. 3962, "Affordable Health Care for America Act," section relating to biosimilars, sections relating to annual and lifetime caps in insurance plans, sections relating to Medicaid eligibility levels, section relating to Medicare Part B therapy cap exceptions process; H.R. 4691, "Temporary Extension Act of 2010," section relating to Medicare Part B therapy cap exceptions process; H.R. 4213, "Tax Extenders Act of 2009," section relating to Medicare Part B therapy cap exceptions process; S.Res. 474, "A resolution supporting the designation of April as Parkinson's Awareness Month;" Medical Device Approval at the Food and Drug Administration.

Client expense: Not reported · Firm income: Not reported

-S. 1273/H.R. 1362, National MS and Parkinson's Disease Registries Act, support all provisions. -S. 1630/H.R. 3799, Affordable Access to Prescription Medications Act, support all provisions. -H.R. 3590, Patient Protection and Affordable Care Act, support provisions improving access to and quality of care for those living with MS. -H.R. 4872, Health Care and Education Reconciliation Act, support provisions improving access to and quality of care for those living with MS. -H.R. 3421, Medical Debt Relief Act, support all provisions. -H.R. 2084, Prevention, Awareness, and Research of Autoimmune Diseases Act, support all provisions.

Client expense: $294,501 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA)

"Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; H.R. 3590, "Patient Protection and Affordable Care Act," regarding the Therapeutic Discovery Project Tax Credit, section relating to expanding access to primary care services and general surgery services, and section relating to the Cures Accerleration Network; H.R. 3962, "Affordable Health Care for America Act," regarding the Therapeutic Discovery Project Tax Credit; H.R. 1362/S. 1273, "The National MS and Parkinson's Disease Registries Act," all sections; Fiscal Year 2011 National Institutes of Health funding.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, President of the U.S., SENATE

-S. 1273/H.R. 1362, National MS and Parkinson's Disease Registries Act, support all provisions. -H.R. 3200, America's Affordable Health Choices Act, support provisions improving access to and quality of care for those living with MS. -H.R. 3962, Affordable Health Care for America Act, support provisions improving access to and quality of care for those living with MS. -H.R. 3590, The Patient Protection and Affordable Care Act, support provisions improving access to and quality of care for those living with MS. -S. 1630/H.R. 3799, Affordable Access to Prescription Medications Act, support all provisions.

Client expense: $87,273 · Firm income: Not reported

Government targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.1362, Bill to reform acquisition practices of the Federal Government and H.R.1873, to reauthorize the programs and activities of the Small Business Administration relating to procurement; FY10 appropriations.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1362, Bill to reform acquisition practices of the Federal Government and H.R.1873, to reauthorize the programs and activities of the Small Business Administration relating to procurement; FY10 appropriations.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; H.R. 2965, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S. 1233, "SBIR/STTR Reauthorization Act of 2009," section 108 regarding Majority-Venture Investments in SBIR Firms and all sections relating to the National Institutes of Health; H.R. 2648, "To authorize the President to award a gold medal on behalf of Congress to Muhammad Ali in recognition of his contributions to the Nation"; Senate Finance Committee "America's Healthy Future Act of 2009," section relating to Therapeutic Discovery Project Tax Credit and regarding modifying Medicare's physician payment formula to encouragehigherquality, lowercostcareforMedicarebeneficiarieswithsevereordisablingchronicconditions; H.R. 3200, "America's Affordable Health Choices Act of 2009," regarding modifying Medicare's physician payment formula to encouragehigherquality, lowercostcareforMedicarebeneficiarieswithsevereordisablingchronicconditions; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).

Client expense: Not reported · Firm income: Not reported

National MS and Parkinson's Disease Registry Act (S. 1273/H.R. 1362); America's Affordable Health Choices Act (H.R. 3200); Promoting Innovation and Access to Lifesaving Medicine Act (H.R. 1427); Affordable Access to Prescription Medications Act (S. 1630/H.R. 3799)

Client expense: $87,273 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)

HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).

Client expense: $5,100 · Firm income: Not reported

Community Choice Act (S. 683/H.R. 1670), Community Living Assistance Services and Supports Act (S. 697/H.R. 1721), Ending the Medicare Disability Waiting Act (H.R. 1708/S. 700), Increase NIH research funding in FY 2010, Health Care Reform, Access to Life-Saving Medicine Act (H.R. 1427/S. 726), National MS and Parkinson's Disease Registries Act (S. 1273/H.R. 1362)

Client expense: $84,996 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)

H.R.1362, Bill to reform acquisition practices of the Federal Government and H.R.1873, to reauthorize the programs and activities of the Small Business Administration relating to procurement; FY10 appropriations.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1362, Bill to reform acquisition practices of the Federal Government and H.R.1873, to reauthorize the programs and activities of the Small Business Administration relating to procurement; FY10 appropriations.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

MS Awareness Resolution (H.Con.Res.14), Comprehensive Health Care Reform, American Recovery & Reinvestment Act of 2009 (HR.1/S.1), Stem Cell Executive Order, State Childrens Health Insurance Program (H.R.2), National MS & Parkinson's Disease Registry (H.R.1362), Community Choice Act (S.683/H.R.1670), CLASS Act (S.697/H.R.1721), Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427/S. 726), Ending the Medicare Disability Waiting Period (H.R. 1708/S. 700)

Client expense: $331,216 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)